Giuseppe Ronzitti

4.3k total citations · 1 hit paper
68 papers, 2.6k citations indexed

About

Giuseppe Ronzitti is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Giuseppe Ronzitti has authored 68 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 37 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in Giuseppe Ronzitti's work include Virus-based gene therapy research (30 papers), RNA Interference and Gene Delivery (12 papers) and Lysosomal Storage Disorders Research (11 papers). Giuseppe Ronzitti is often cited by papers focused on Virus-based gene therapy research (30 papers), RNA Interference and Gene Delivery (12 papers) and Lysosomal Storage Disorders Research (11 papers). Giuseppe Ronzitti collaborates with scholars based in France, Italy and United States. Giuseppe Ronzitti's co-authors include Federico Mingozzi, Pasqualina Colella, David‐Alexandre Gross, Fanny Collaud, Christian Leborgne, Gian Paolo Rossini, Evelina Chieregatti, Séverine Charles, Laetitia van Wittenberghe and Marcelo Simon Sola and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Giuseppe Ronzitti

64 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging Issues in AAV-Mediated In Vivo Gene Therapy

2017 617 citations Pasqualina Colella, Giuseppe Ronzitti et al. Molecular Therapy — Methods & Clinical Development profile →

Peers

Giuseppe Ronzitti

GENET

ONCOL

CMN

PHYSI

Gunnar Houge Norway

Hanka Venselaar Netherlands

Alfonso González Chile

Peter Frommolt Germany

Nathalie Clément United States

Shunzo Kondo Japan

Samuel S. Chong Singapore

Ralph Witzgall Germany

John Hanna United States

Jeremy Schwartzentruber Canada

Gunnar Houge Norway

Giuseppe Ronzitti

1.8k ×1.2

812 ×0.7

GENET

187 ×0.5

ONCOL

171 ×0.6

CMN

899 ×3.1

PHYSI

Citations per year, relative to Giuseppe Ronzitti Giuseppe Ronzitti (= 1×) peers Gunnar Houge

Countries citing papers authored by Giuseppe Ronzitti

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Ronzitti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Ronzitti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Ronzitti more than expected).

Fields of papers citing papers by Giuseppe Ronzitti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Ronzitti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Ronzitti. The network helps show where Giuseppe Ronzitti may publish in the future.

Co-authorship network of co-authors of Giuseppe Ronzitti

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Ronzitti. A scholar is included among the top collaborators of Giuseppe Ronzitti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Ronzitti. Giuseppe Ronzitti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cosette, Jérémie, Guillaume Corre, Nemanja Vujić, et al.. (2025). Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transfer. Communications Medicine. 5(1). 110–110. 1 indexed citations

Collaud, Fanny, Verónica Jiménez, Xavier León, et al.. (2025). A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease. Molecular Therapy — Methods & Clinical Development. 33(2). 101464–101464.

Bella, Tiziana La, et al.. (2024). Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness. Molecular Therapy — Methods & Clinical Development. 32(3). 101327–101327. 1 indexed citations

Shi, Xiaoxia, Giulia Bortolussi, Fanny Collaud, et al.. (2024). Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I. Molecular Therapy — Methods & Clinical Development. 32(4). 101363–101363. 2 indexed citations

Vidal, Pierre, Benjamin Bertin, Evelyne Gicquel, et al.. (2023). Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa^−/− mice. Journal of Inherited Metabolic Disease. 47(1). 119–134. 9 indexed citations

Piletska, Elena, et al.. (2022). Evading and overcoming AAV neutralization in gene therapy. Trends in biotechnology. 41(6). 836–845. 49 indexed citations

Barbon, Elena, Charlotte Kawecki, Solenne Marmier, et al.. (2021). Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene Therapy. 30(3-4). 245–254. 25 indexed citations

Zhukouskaya, Volha V., Séverine Charles, Christian Leborgne, et al.. (2021). A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Science Advances. 7(44). eabj5018–eabj5018. 5 indexed citations

Ronzitti, Giuseppe, David‐Alexandre Gross, & Federico Mingozzi. (2020). Human Immune Responses to Adeno-Associated Virus (AAV) Vectors. Frontiers in Immunology. 11. 670–670. 241 indexed citations

10.

Chappert, Pascal, Dominique Urbain, Fanny Collaud, et al.. (2019). Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity. JCI Insight. 4(11). 17 indexed citations

11.

Aronson, Sem J., Xiaoxia Shi, Suzanne Duijst, et al.. (2019). Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. Journal of Hepatology. 71(1). 153–162. 37 indexed citations

12.

Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations

13.

Mithieux, Gilles, et al.. (2019). Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III. Human Gene Therapy. 30(10). 1263–1273. 16 indexed citations

14.

Boisgérault, Florence, Romain Hardet, Solenne Marmier, et al.. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications. 9(1). 4098–4098. 203 indexed citations

15.

Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations

16.

Han, Sang-oh, Giuseppe Ronzitti, Christian Leborgne, et al.. (2017). Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. Molecular Therapy — Methods & Clinical Development. 4. 126–136. 60 indexed citations

17.

Ronzitti, Giuseppe, Giulia Bortolussi, Remco van Dijk, et al.. (2016). A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Molecular Therapy — Methods & Clinical Development. 3. 16049–16049. 48 indexed citations

18.

Ronzitti, Giuseppe, Gabriele Bucci, Marco Emanuele, et al.. (2014). Exogenous -Synuclein Decreases Raft Partitioning of Cav2.2 Channels Inducing Dopamine Release. Journal of Neuroscience. 34(32). 10603–10615. 52 indexed citations

19.

Ronzitti, Giuseppe & Gian Paolo Rossini. (2007). Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cells. Toxicology. 244(2-3). 145–156. 15 indexed citations

20.

Ronzitti, Giuseppe, et al.. (2004). Selective disruption of the E-cadherin–catenin system by an algal toxin. British Journal of Cancer. 90(5). 1100–1107. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact